| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |